In Brief: Allergan v. Staar Surgical
This article was originally published in The Gray Sheet
Allergan v. Staar Surgical: Allergan reports June 16 that a jury in the U.S. District Court for the Central District of California has determined that Microtech and Allergan are the "owner and exclusive licensee, respectively" of U.S. patent No. 4,681,102, which covers the "Bartell Shooter" instrument and a method for inserting intraocular lenses into the eye during cataract surgical procedures. Allergan filed suit in November 1992 seeking "injunctive relief and compensatory and treble damages resulting from willful infringement" by Staar, which claimed ownership of the patent ("The Gray Sheet" Nov. 30, 1992, p. 16). The jury found that neither Staar nor Chiron, which has a sublicense to the patent from Staar, has any rights to the Bartell invention. "As a result of this verdict, we intend to vigorously pursue our claims of willful infringement against Staar and Chiron," Allergan says...
You may also be interested in...
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.